gimli
ABBOTINDIA stock analysis context
ABBOTT INDIA Stock Context for AI Screening
ABBOTT INDIA LIMITED is a mid-cap stock in Healthcare. This page summarizes key screening signals for ABBOTT INDIA, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Open interactive ABBOTINDIA stock pagePrice
₹26,245.00
1W return
+2.72%
1M return
+1.80%
3M return
+1.53%
6M return
-7.39%
1Y return
-23.17%
Market cap
₹55,768.79 cr
PE
35.93
PB
11.68
ROE
+34.46%
ROCE
+44.89%
RSI
51.32
Turnover
₹13.77 cr
Why it can matter in screens
- Momentum: ABBOTINDIA is trend mixed or unavailable; RSI is 51.32.
- Returns: 1D -1.80%, 1W +2.72%, 1M +1.80%, 3M +1.53%, 1Y -23.17%.
- Trend levels: 52W high ₹35,195.00, 52W low ₹25,180.00, off high -25.43%.
- Liquidity: latest turnover is ₹13.77 cr; volume vs 20D is +0.44%.
- Valuation/profitability: PE 35.93, PB 11.68, ROE +34.46%, ROCE +44.89%.
- Growth: 3Y sales CAGR +9.02%, 3Y profit CAGR +17.80%.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 1,709.51 cr | 556.44 cr | 394.93 cr | 185.85 |
| 2025-12-31 | 1,724.04 cr | 533.23 cr | 375.96 cr | 176.92 |
| 2025-09-30 | 1,757.15 cr | 572.12 cr | 415.27 cr | 195.42 |
| 2025-06-30 | 1,738.35 cr | 518.43 cr | 365.86 cr | 172.17 |
| 2025-03-31 | 1,604.59 cr | 504.56 cr | 367.04 cr | 172.72 |
| 2024-12-31 | 1,614.28 cr | 507.84 cr | 360.78 cr | 169.78 |
| 2024-09-30 | 1,632.67 cr | 499.44 cr | 358.61 cr | 168.76 |
| 2024-06-30 | 1,557.61 cr | 458.34 cr | 328.01 cr | 154.36 |
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 6,929.05 cr | 2,180.22 cr | 1,552.02 cr | 730.36 |
| 2025-03-31 | 6,409.15 cr | 1,970.18 cr | 1,414.44 cr | 665.62 |
| 2024-03-31 | 5,847.19 cr | 1,701.37 cr | 1,201.22 cr | 565.28 |
| 2023-03-31 | 5,346.73 cr | 1,359.78 cr | 949.41 cr | 446.78 |
| 2022-03-31 | 4,996.48 cr | 1,164.93 cr | 798.70 cr | 375.87 |
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 6,501.93 cr | 442.33 cr | 171.99 cr | 4,774.19 cr |
| 2025-03-31 | 5,917.31 cr | 560.59 cr | 196.67 cr | 4,233.15 cr |
| 2024-03-31 | 5,193.49 cr | 291.74 cr | 83.23 cr | 3,698.89 cr |
| 2023-03-31 | 4,555.51 cr | 239.67 cr | 113.17 cr | 3,188.54 cr |
| 2022-03-31 | 4,224.12 cr | 132.71 cr | 151.69 cr | 2,819.79 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 1,319.24 cr | 1,278.32 cr | n/a |
| 2025-03-31 | 1,011.84 cr | 959.24 cr | n/a |
| 2024-03-31 | 1,212.81 cr | 1,164.48 cr | n/a |
| 2023-03-31 | 893.39 cr | 859.28 cr | n/a |
| 2022-03-31 | 947.66 cr | 903.59 cr | n/a |
Shareholding Trend
No recent data available.
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 453,042.43 cr | 39.400236 | +14.71% | +12.90% |
| DIVISLAB | DIVI S LABORATORIES LTD | 179,324.04 cr | 69.830233 | +16.19% | -2.64% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 164,701.07 cr | 76.144739 | +17.18% | +46.47% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 125,861.94 cr | 64.267738 | +21.03% | +15.71% |
| CIPLA | CIPLA LTD | 115,660.88 cr | 29.801362 | +11.79% | -3.80% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 115,515.66 cr | 23.036787 | +17.93% | +16.76% |
| LUPIN | LUPIN LIMITED | 112,429.39 cr | 21.054508 | +26.83% | +27.93% |
| DRREDDY | DR. REDDY S LABORATORIES | 112,317.04 cr | 26.207396 | +11.94% | +5.08% |
Try these prompts
- Analyze ABBOTT INDIA with valuation, momentum and industry peers
- Compare ABBOTINDIA with other Healthcare stocks
- Show mid-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View mid-cap stocks
- Find stocks above 50DMA
- Compare ABBOTINDIA with other Healthcare stocks
Data snapshot: 2026-07-08. Not investment advice.